CLINICAL ROLE -
In a Nod to Precision Oncology, the FDA Approves Revumenib
The approval marks a significant milestone in the treatment of a rare and aggressive subtype of acute leukemia.
Read More
Patient-Reported Outcomes Reinforce Clinical Benefits of Tarlatamab in Small Cell Lung Cancer
Executive Order Advances Price Transparency Efforts to Lower Health Care Costs
Alcohol Initiation, Cessation Associated With Dose-Dependent Changes in LDL, HDL Cholesterol
Regulating Cholesterol May Enhance T-Cell Function in Patients With Chronic Lymphocytic Leukemia